A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxisWilliam J Moore, Sajal D. Tanna, C Boutin|Current Opinion in Infectious Diseases|2023Cited by 5